“…All of the studies were developed and delivered in Europe: Norway (Bugge et al, ), Denmark and Germany (Thastum et al, ), Finland (Niemelä, Repo, Wahlberg, Hakko, & Räsänen, ), and France (Landry‐Dattée et al, ). There were two qualitative studies with no control group (Bugge et al, ; Landry‐Dattée et al, ): a quantitative randomised controlled trial (Niemelä et al, ) and a semi‐controlled mixed methods design study (Thastum et al, ). One of the studies focused exclusively on parents with end‐stage cancer (Bugge et al, ) and the remaining three studies included—but was not limited to—parents with end‐stage cancer (Landry‐Dattée et al, ; Niemelä et al, ; Thastum et al, ).…”